Article
Genetic variants of the nuclear factor erythroid 2-related factor 2/antioxidant reaction element pathway on the risk of antituberculosis drug-induced liver injury: a systematic review.
Pharmacogenomics - 1 Apr 2023
Hao Zhuolu, Zhang Meiling, Chen Xinyu, Zhu Min, Han Bing, He Yiwen, Yi Honggang, Tang Shaowen
Abstract excerpt
Aim: To evaluate the effects of genetic variants in the nuclear factor erythroid 2-related factor 2/antioxidant reaction element signaling pathway on antituberculosis drug-induced liver injury (AT-DILI) susceptibility. Methods: The PubMed, Embase, Cochrane, Web of Science, China National Knowledge Infrastructure and Wanfang databases were searched from inception to April 2022. Results: Seven case-control studies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.